Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Linaclotide (Linzess) for Irritable Bowel syndrome With Constipation and For Chronic Idiopathic Constipation.

Literature DB >> 23641133

Linaclotide (Linzess) for Irritable Bowel syndrome With Constipation and For Chronic Idiopathic Constipation.

Rachel Hutchins Thomas, Kyle Allmond.

Abstract

Linaclotide (Linzess) for irritable bowel syndrome with constipation and for chronic idiopathic constipation.

Entities: Chemical Disease

Year: 2013 PMID： 23641133 PMCID： PMC3638410

Source DB: PubMed Journal: P T ISSN： 1052-1372

19 in total

1. Guanylyl cyclase is a heat-stable enterotoxin receptor.

Authors: S Schulz; C K Green; P S Yuen; D L Garbers
Journal: Cell Date: 1990-11-30 Impact factor: 41.582

Review 2. An evidence-based position statement on the management of irritable bowel syndrome.

Authors: Lawrence J Brandt; William D Chey; Amy E Foxx-Orenstein; Lawrence R Schiller; Philip S Schoenfeld; Brennan M Spiegel; Nicholas J Talley; Eamonn M M Quigley
Journal: Am J Gastroenterol Date: 2009-01 Impact factor: 10.864

Review 3. Linaclotide - a secretagogue and antihyperalgesic agent - what next?

Authors: A E Bharucha; D R Linden
Journal: Neurogastroenterol Motil Date: 2010-03 Impact factor: 3.598

Review 4. Functional bowel disorders.

Authors: George F Longstreth; W Grant Thompson; William D Chey; Lesley A Houghton; Fermin Mearin; Robin C Spiller
Journal: Gastroenterology Date: 2006-04 Impact factor: 22.682

5. Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract.

Authors: Alexander P Bryant; Robert W Busby; Wilmin P Bartolini; Etchell A Cordero; Gerhard Hannig; Marco M Kessler; Christine M Pierce; Robert M Solinga; Jenny V Tobin; Shalina Mahajan-Miklos; Mitchell B Cohen; Caroline B Kurtz; Mark G Currie
Journal: Life Sci Date: 2010-03-20 Impact factor: 5.037

Review 6. Epidemiology of constipation in North America: a systematic review.

Authors: Peter D R Higgins; John F Johanson
Journal: Am J Gastroenterol Date: 2004-04 Impact factor: 10.864

7. Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.

Authors: H Eutamene; S Bradesi; M Larauche; V Theodorou; C Beaufrand; G Ohning; J Fioramonti; M Cohen; A P Bryant; C Kurtz; M G Currie; E A Mayer; L Bueno
Journal: Neurogastroenterol Motil Date: 2009-08-25 Impact factor: 3.598

Review 8. Lubiprostone: a chloride channel activator for treatment of chronic constipation.

Authors: Emily M Ambizas; Regina Ginzburg
Journal: Ann Pharmacother Date: 2007-05-22 Impact factor: 3.154

9. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation.

Authors: Satish Rao; Anthony J Lembo; Steven J Shiff; Bernard J Lavins; Mark G Currie; Xinwei D Jia; Kelvin Shi; James E MacDougall; James Z Shao; Paul Eng; Susan M Fox; Harvey A Schneier; Caroline B Kurtz; Jeffrey M Johnston
Journal: Am J Gastroenterol Date: 2012-11 Impact factor: 10.864

Review 10. Guidelines on the irritable bowel syndrome: mechanisms and practical management.

Authors: R Spiller; Q Aziz; F Creed; A Emmanuel; L Houghton; P Hungin; R Jones; D Kumar; G Rubin; N Trudgill; P Whorwell
Journal: Gut Date: 2007-05-08 Impact factor: 23.059

7 in total

1. Linaclotide pharmacodynamics.

Authors: Robert W Busby; George Zhang
Journal: P T Date: 2013-07

2. Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion.

Authors: Yogesh Bhattarai; Brianna B Williams; Eric J Battaglioli; Weston R Whitaker; Lisa Till; Madhusudan Grover; David R Linden; Yasutada Akiba; Karunya K Kandimalla; Nicholas C Zachos; Jonathan D Kaunitz; Justin L Sonnenburg; Michael A Fischbach; Gianrico Farrugia; Purna C Kashyap
Journal: Cell Host Microbe Date: 2018-06-13 Impact factor: 21.023